Evaluation and suggested improvements of the Biopharmaceutics Classification System (BCS). (Q36885229)

16 August 2017

1 reference

title

Evaluation and suggested improvements of the Biopharmaceutics Classification System (BCS). (English)

1 reference

16 August 2017

Urban Fagerholm

1

1 reference

16 August 2017

publication date

1 June 2007

1 reference

Journal of Pharmacy and Pharmacology

16 August 2017

published in

1 reference

16 August 2017

volume

59

1 reference

16 August 2017

issue

6

1 reference

16 August 2017

page(s)

751-757

1 reference

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Caco-2 monolayers in experimental and theoretical predictions of drug transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Direct estimation of the in vivo dissolution of spironolactone, in two particle size ranges, using the single-pass perfusion technique (Loc-I-Gut) in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Predicting passive transport in silico--history, hype, hope

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Absorption potential: estimating the fraction absorbed for orally administered compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Clinical pharmacokinetics of the cyclooxygenase inhibiting nitric oxide donator (CINOD) AZD3582.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Comparison between permeability coefficients in rat and human jejunum

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Physiologically-based pharmacokinetic simulation modelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Molecular properties of WHO essential drugs and provisional biopharmaceutical classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Development of level A, B and C in vitro-in vivo correlations for modified-release levosimendan capsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Characterization of fluids from the stomach and proximal jejunum in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Exploring the role of different drug transport routes in permeability screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Prediction of the oral absorption of low-permeability drugs using small intestine-like 2/4/A1 cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

An improved cell culture model based on 2/4/A1 cell monolayers for studies of intestinal drug transport: characterization of transport routes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

A physiological model for the estimation of the fraction dose absorbed in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

A 'rule of unity' for human intestinal absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Correlating partitioning and caco-2 cell permeability of structurally diverse small molecular weight compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

The "high solubility" definition of the current FDA Guidance on Biopharmaceutical Classification System may be too strict for acidic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

Evaluation of rat intestinal absorption data and correlation with human intestinal absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.6.0001

21 January 2018

Identifiers

DOI

10.1211/JPP.59.6.0001

1 reference

16 August 2017

1 reference